Trabectedin has been approved for second-line treatment of soft tissue sarcomas. However, its efficacy to target sarcoma initiating cells has not been addressed yet. Here, we used pioneer models of myxoid/round cell liposarcoma (MRCLS) and undifferentiated pleomorphic sarcoma (UPS) developed from transformed human mesenchymal stromal/stem cells (MSCs) to evaluate the effect of trabectedin in the cell type responsible for initiating sarcomagenesis and their derived cancer stem cells (CSC) subpopulations.
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2ren1SW
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
You know the feeling: you're hanging out somewhere, you look across the room, and suddenly your stomach drops. You start to sweat. Your ...
-
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2o7K1Dm via IFTTT
-
What is now Middlesex University was originally a vision for a People's University: A polytechnic that would unite science, society and ...
-
About IRF. The Incentive Research Foundation (IRF), a private not-for-profit foundation, funds research studies and develops products servin...
-
Zusammenfassung Klinisches/methodisches Problem Akquisitionen in der Computertomographie (CT) sollten immer nach dem ALARA-Prinzip („as ...
-
University of sydney essay writing guide - professional writers, top-notch services, instant delivery and other advantages can be found in o...
-
We Are a Leadership Development Company. Harvard Business Publishing Corporate Learning partners with clients to create world-class leadersh...
-
It is not so easy to choose proper essay topics. Certainly, students have to do it for their essay writing. Once the topic for an essay is s...
-
Inflatable Penile Prosthesis | Malleable Penile Prosthesis Implant Surgery with Penis Enlargement Phalloplasty from #AlexandrosSfakianakis...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου